促销时间表 Nyxoah S.A.
先进的时间表
简单图表
关于公司
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
| IPO date |
2021-07-02 |
| ISIN |
BE0974358906 |
| Industry |
Health Care Equipment & Supplies |
| Sector |
Health Care |
| Валюта |
usd |
| Валюта отчета |
eur |
| Сайт |
https://www.nyxoah.com
|
| Цена ао |
9.03 |
| 每周价格变化: |
-0.1248% (8.01) |
| 每月价格变化: |
-4.65% (8.39) |
| 3个月内价格变化: |
-17.53% (9.7) |
| 六个月内的价格变化: |
+8.25% (7.39) |
| 每年价格变化: |
+72.41% (4.64) |
| 3年内价格变化: |
-60% (20) |
|
|
低估
| 姓名 |
意义 |
年级 |
| P/S |
27.54 |
1 |
| P/BV |
1.22 |
9 |
| P/E |
0 |
0 |
| EV/EBITDA |
-2.56 |
0 |
| 全部的: |
|
4.5 |
|
效率
| 姓名 |
意义 |
年级 |
| ROA, % |
-34.8 |
0 |
| ROE, % |
-44.04 |
0 |
| 全部的: |
|
0 |
|
|
|
股息
| 姓名 |
意义 |
年级 |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| 全部的: |
|
0 |
|
责任
| 姓名 |
意义 |
年级 |
| Debt/EBITDA |
-0.2215 |
10 |
| 全部的: |
|
10 |
|
成长冲动
| 姓名 |
意义 |
年级 |
| 盈利能力 Revenue, % |
6201.45 |
10 |
| 盈利能力 Ebitda, % |
532.78 |
10 |
| 盈利能力 EPS, % |
372.2 |
10 |
| 全部的: |
|
10 |
|
| 导师 |
职称 |
支付 |
出生年份 |
| Mr. Robert Taub MBA |
Co-Founder & Chairman |
138.98k |
1947 (78 年) |
| Mr. Olivier Taelman |
CEO & Executive Director |
878.86k |
1971 (54 年) |
| Mr. Loic Moreau |
Chief Financial Officer |
510.36k |
1981 (44 年) |
| Mr. Bruno Onkelinx |
Chief Technology Officer |
N/A |
|
| Mikaela Kirkwood |
Corporate Communication & Investor Relations Manager |
N/A |
|
| Ms. An Moonen |
General Counsel |
N/A |
|
| Mr. Jeyakumar Subbaroyan |
Chief Clinical Officer |
N/A |
|
| Ms. Inge Vanwittenbergh |
Global Human Resource Director |
|
|
| Mr. David M. DeMartino |
Chief Strategy Officer |
|
|
| Mr. Remi Renard |
Chief of Staff |
|
|
